About the Authors
- Lorenza Mittempergher
-
Contributed equally to this work with: Lorenza Mittempergher, Jorma J. de Ronde
Affiliation Divisions of Experimental Therapy, Molecular Biology, Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Jorma J. de Ronde
-
Contributed equally to this work with: Lorenza Mittempergher, Jorma J. de Ronde
Affiliation Divisions of Experimental Therapy, Molecular Biology, Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Marja Nieuwland
-
Affiliation Central Microarray Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Ron M. Kerkhoven
-
Affiliation Central Microarray Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Iris Simon
-
Affiliation Agendia BV, Amsterdam, The Netherlands
- Emiel J. Th. Rutgers
-
Affiliation Divisions of Experimental Therapy, Molecular Biology, Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Lodewyk F. A. Wessels
-
Affiliation Divisions of Experimental Therapy, Molecular Biology, Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Laura J. Van't Veer
-
* E-mail: l.vt.veer@nki.nl
Affiliations Divisions of Experimental Therapy, Molecular Biology, Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands, Agendia BV, Amsterdam, The Netherlands
Competing Interests
LJVV is a named inventor on a patent for the 70-gene signature used in this study and is a shareholder in Agendia BV, the commercial entity that markets the 70-gene signature as MammaPrint®. IS is employed by Agendia BV. However, what is stated above does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: LM LJVV EJTR. Performed the experiments: LM MN RMK. Analyzed the data: LM JJR LJVV LFAW. Contributed reagents/materials/analysis tools: IS RMK. Wrote the paper: LM JJR LJVV LFAW.